Back to results
CompletedPhase 2

Bexarotene Amyloid Treatment for Alzheimer's Disease

NCT01782742

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Cleveland Clinic Lou Ruvo Center for Brain Health

Las Vegas, Nevada, United States

View on ClinicalTrials.gov
Bexarotene Amyloid Treatment for Alzheimer's Disease — TrialFind